EUVIMEDEUVIMED entdecken
Crossref

Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma

Kentaro Mizuhara, Yuji Shimura iD, Taku Tsukamoto, Akinori Kanai, Saeko Kuwahara-Ota, Junko Yamaguchi, Ayako Muramatsu, Haruya Okamoto, Yoko Taminishi-Katsuragawa, Yuka Kawaji-Kanayama, Reiko Isa, Shinsuke Mizutani und 2 weitere

British Journal of Haematology · 2023-11 · 203 (3) · 426-438

DOI: 10.1111/bjh.19049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 16.08.2023. Verfasst von Kentaro Mizuhara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Multiple Myeloma, Exosomes, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Grants-in-Aid for Scientific Research (KAKENHI) Program, Japan Agency for Medical Research and Development, SENSHIN Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The shift of the tumour immune microenvironment to a suppressive state promotes not only the development and progression of the disease in multiple myeloma (MM) but also the development of resistance to immunotherapy. We previously demonstrated that myeloma cells can induce monocytic myeloid‐derived suppressor cells (M‐MDSCs) from healthy peripheral blood mononuclear cells (PBMCs) via the concomitant secretion of CC motif chemokine ligand 5 (CCL5) and macrophage migration inhibitory factor (MIF), but an unknown mediator also promotes M‐MDSC induction. This study demonstrates that miR‐106a‐5p and miR‐146a‐5p delivered by tumour‐derived exosomes (TEXs) from myeloma cells play essential roles in M‐MDSC induction in MM. MiR‐106a‐5p and miR‐146a‐5p upregulate various immunosuppressive/inflammatory molecules in PBMCs, such as IDO1, CD38, programmed death‐ligand 1, CCL5 or MYD88, which are involved in interferon (IFN)‐α response, IFN‐γ response, inflammatory response, tumour necrosis factor‐α signalling and Interleukin‐6‐JAK–STAT3 signalling. These molecular features mirror the increases in myeloid cellular compartments of PBMCs when co‐cultured with myeloma cells. MiR‐106a‐5p and miR‐146a‐5p have a compensatory relationship, and these two miRNAs collaborate with CCL5 and MIF to promote M‐MDSC induction. Collectively, novel therapeutic candidates may be involved in TEX‐mediated sequential cellular and molecular events underlying M‐MDSC induction, potentially improving the efficacy of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMultiple MyelomaExosomesMyeloid-Derived Suppressor CellsLeukocytes, MononuclearMonocytesRNA, NeoplasmHumansTumor MicroenvironmentCell Line, TumorChemokine CCL5

Stichwörter der Autor:innen

exosomesinterferon responsemiRNAsmonocytic myeloid-derived suppressor cellsmultiple myeloma

Substanzen

MicroRNAsMIRN146 microRNA, humanMIRN106 microRNA, humanRNA, NeoplasmChemokine CCL5

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Department of Hematology, Japan Community Health Care Organization, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.

ORCID-Profile: Yuji Shimura, Junya Kuroda

Förderung

  • Grants-in-Aid for Scientific Research (KAKENHI) Program
  • Japan Agency for Medical Research and Development
  • SENSHIN Medical Research Foundation
  • The Japanese Society of Hematology Research Grant
  • The Japanese Society of Myeloma Research Award

Zitieren

APA

Mizuhara, K., Shimura, Y., Tsukamoto, T., Kanai, A., Kuwahara-Ota, S., Yamaguchi, J., Muramatsu, A., Okamoto, H., Taminishi-Katsuragawa, Y., Kawaji-Kanayama, Y., Isa, R., Mizutani, S., Inaba, T., & Kuroda, J. (2023). Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma. British Journal of Haematology, 203(3), 426-438. https://doi.org/10.1111/bjh.19049

Vancouver

Mizuhara K, Shimura Y, Tsukamoto T, Kanai A, Kuwahara-Ota S, Yamaguchi J, et al. Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma. British Journal of Haematology. 2023;203(3):426-438. doi:10.1111/bjh.19049

BibTeX
@article{Mizuhara2023,
  author = {Mizuhara, Kentaro and Shimura, Yuji and Tsukamoto, Taku and Kanai, Akinori and Kuwahara-Ota, Saeko and Yamaguchi, Junko and Muramatsu, Ayako and Okamoto, Haruya and Taminishi-Katsuragawa, Yoko and Kawaji-Kanayama, Yuka and Isa, Reiko and Mizutani, Shinsuke and Inaba, Toshiya and Kuroda, Junya},
  title = {Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {203},
  number = {3},
  pages = {426--438},
  doi = {10.1111/bjh.19049}
}
Kostenlos starten →